Lunai Bioworks Inc. (LNAI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 15K 30K 45K Q1 '13: 31.6K Q2 '13: 0 Q3 '13: 925 Q4 '13: 285 Q4 '15: 42.5K Q1 '16: 0 Q1 '26: 20.9K Q1 '13 Q2 '13 Q3 '13 Q4 '13 Q4 '15 Q1 '16 Q1 '26

Gross Profit Quarterly

-150K -100K -50K 0 50K 100K 150K Q3 '14: -143.5K Q4 '14: -70.2K Q1 '15: -44.6K Q2 '15: -21.3K Q4 '15: 37.3K Q1 '16: 0 Q2 '16: 213 Q1 '26: 20.9K Q3 '14 Q4 '14 Q1 '15 Q2 '15 Q4 '15 Q1 '16 Q2 '16 Q1 '26

Operating Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q2 '24: -17.1M Q3 '24: -53.3M Q4 '24: -4.5M Q1 '25: -4.2M Q2 '25: -126.9M Q3 '25: -3.3M Q4 '25: -1.8M Q1 '26: -1.5M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Net Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q2 '24: -15.7M Q3 '24: -44.2M Q4 '24: -7.3M Q1 '25: 189.2K Q2 '25: -126.7M Q3 '25: 2.8M Q4 '25: -1.8M Q1 '26: -2.6M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-2.7M -1.8M -900K 0 900K 1.8M 2.7M Q2 '24: -2.4M Q3 '24: -2M Q4 '24: -2.6M Q1 '25: -1.5M Q2 '25: -1.8M Q3 '25: -1.3M Q4 '25: -1.1M Q1 '26: -1M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q4 '21: -4.6M Q1 '22: -2.8M Q2 '22: -3.1M Q1 '23: -3.3M Q2 '23: -2.3M Q1 '24: -2.6M Q2 '24: -2.4M Q1 '26: -1M Q4 '21 Q1 '22 Q2 '22 Q1 '23 Q2 '23 Q1 '24 Q2 '24 Q1 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q4 '23: 65.9M Q1 '24: 109.2M Q3 '24: 16M Q4 '24: 16.2M Q1 '25: 16.4M Q3 '25: 22.5M Q4 '25: 23.5M Q1 '26: 25M Q4 '23 Q1 '24 Q3 '24 Q4 '24 Q1 '25 Q3 '25 Q4 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q2 '23: -0.71 Q3 '23: -0.71 Q4 '23: -0.70 Q1 '24: -1.16 Q2 '24: -0.75 Q3 '24: -3.37 Q4 '24: -3.75 Q1 '25: -3.21 Q2 '23 Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.